ProTreat: an adaptive and rapid implementation trial of novel therapies to prevent and treat COVID-19 infection in high risk cancer patients
- Funded by Medical Research Future Fund (MRFF)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
- Disease COVID-19
- Known Financial Commitments (USD) $3,935,388.68
- Funder Medical Research Future Fund (MRFF)
- Principal Investigator .
- Research Location Australia
- Lead Research Institution University of Melbourne
- Research Priority Alignment N/A
- Research Category - Therapeutics research, development and implementation 
- Research Subcategory - Clinical trial (unspecified trial phase) 
- Special Interest Tags - N/A 
- Study Type - Clinical 
- Clinical Trial Details - Unspecified 
- Broad Policy Alignment - Pending 
- Age Group - Unspecified 
- Vulnerable Population - Unspecified 
- Occupations of Interest - Unspecified 
Abstract
MRFF Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity research recipient